Twelve patients were initially diagnosed as anaplastic astrocytoma, IDH-wildtype, and reclassified as H3-wildtype and IDH-wildtype diffuse pediatric-type high-grade glioma according to the 2021 WHO classification of CNS tumors (Louis et al., 2016). This evidence concerns the gene IDH1 and central nervous system cancer.